Agritech New Zealand

agritechnz.org.nz

Launched in 2018, Agritech New Zealand is a purpose driven, membership funded organisation whose members share a passion for the opportunities that agritech can generate. Agritech New Zealand connects innovators, investors, regulators, researchers and interested public. It promotes opportunities and challenges raised by agritech.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Diagnostics

MERIDIAN LAUNCHES NEW QPCR MASTER MIXES FOR STOOL SAMPLES TO ACCELERATE DEVELOPMENT OF MOLECULAR ASSAYS

Meridian | June 21, 2022

news image

Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today two new sample-specific master mixes, Lyo-Ready™ Direct DNA qPCR Stool Mix, and Lyo-Ready™ Direct RNA/DNA qPCR Stool Mix. These innovative master mixes improve the molecular detection of DNA and RNA from crude fecal specimens while allowing room temperature stabilization of diagnostic assays. Stool samples are used in many ...

Read More

Medical

HTL ANNOUNCES ITS INCUBATOR'S EQUITY INVESTMENT IN GELMEDIX, AN EARLY-STAGE BIOTECH AIMING AT REVOLUTIONIZING OCULAR AND REGENERATIVE THERAPIES

HTL | March 14, 2022

news image

HTL Biotechnology, a pioneer and world leader in the development and production of innovative pharmaceutical grade biopolymers, today announced its incubator's first equity investment in GelMEDIX Inc., an early-stage biotechnology company committed to developing the next generation of ocular and regenerative therapies. This investment supports continued development of the GelMEDIX platform, which enables the delivery of therapeutics from small molecules to cell and gene therap...

Read More

Cell and Gene Therapy

BIOCENTRIQ® AND KYTOPEN® EXPAND PARTNERSHIP TO EXPEDITE IMPACT OF TRANSFORMATIVE GENE-EDITING TECHNOLOGY ON CELL THERAPY MANUFACTURING

PRNewswire | June 12, 2023

news image

BioCentriq®, a strategic CDMO specializing in cell therapy announced that it has expanded its partnership with Kytopen, a Cambridge based startup spun out of Massachusetts Institute of Technology (MIT). The partnership was originally announced in March of 2021. In the initial phase of the collaboration, the Kytopen and BioCentriq teams worked together to test transfection of T-cells using Kytopen's Flowfect® technology and the potential impact to both autologous and ...

Read More

AI, Diagnostics

GENOMIC VISION ANNOUNCES LAUNCH OF FIBERSMART

Genomic Vision | March 08, 2023

news image

On March 7, 2023, Genomic Vision, a leading biotech company that develops products and services for the analysis and control of genome changes, launched FiberSmart®, an AI-based technology for automating the quantification and detection of fluorescent signals on combed DNA molecules. Initially available for the analysis of Replication Combing Assays (RCA), Genomic Vision's proprietary method for directly visualizing DNA replication kinetics at the single molecule level. ...

Read More
news image

Diagnostics

MERIDIAN LAUNCHES NEW QPCR MASTER MIXES FOR STOOL SAMPLES TO ACCELERATE DEVELOPMENT OF MOLECULAR ASSAYS

Meridian | June 21, 2022

Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today two new sample-specific master mixes, Lyo-Ready™ Direct DNA qPCR Stool Mix, and Lyo-Ready™ Direct RNA/DNA qPCR Stool Mix. These innovative master mixes improve the molecular detection of DNA and RNA from crude fecal specimens while allowing room temperature stabilization of diagnostic assays. Stool samples are used in many ...

Read More
news image

Medical

HTL ANNOUNCES ITS INCUBATOR'S EQUITY INVESTMENT IN GELMEDIX, AN EARLY-STAGE BIOTECH AIMING AT REVOLUTIONIZING OCULAR AND REGENERATIVE THERAPIES

HTL | March 14, 2022

HTL Biotechnology, a pioneer and world leader in the development and production of innovative pharmaceutical grade biopolymers, today announced its incubator's first equity investment in GelMEDIX Inc., an early-stage biotechnology company committed to developing the next generation of ocular and regenerative therapies. This investment supports continued development of the GelMEDIX platform, which enables the delivery of therapeutics from small molecules to cell and gene therap...

Read More
news image

Cell and Gene Therapy

BIOCENTRIQ® AND KYTOPEN® EXPAND PARTNERSHIP TO EXPEDITE IMPACT OF TRANSFORMATIVE GENE-EDITING TECHNOLOGY ON CELL THERAPY MANUFACTURING

PRNewswire | June 12, 2023

BioCentriq®, a strategic CDMO specializing in cell therapy announced that it has expanded its partnership with Kytopen, a Cambridge based startup spun out of Massachusetts Institute of Technology (MIT). The partnership was originally announced in March of 2021. In the initial phase of the collaboration, the Kytopen and BioCentriq teams worked together to test transfection of T-cells using Kytopen's Flowfect® technology and the potential impact to both autologous and ...

Read More
news image

AI, Diagnostics

GENOMIC VISION ANNOUNCES LAUNCH OF FIBERSMART

Genomic Vision | March 08, 2023

On March 7, 2023, Genomic Vision, a leading biotech company that develops products and services for the analysis and control of genome changes, launched FiberSmart®, an AI-based technology for automating the quantification and detection of fluorescent signals on combed DNA molecules. Initially available for the analysis of Replication Combing Assays (RCA), Genomic Vision's proprietary method for directly visualizing DNA replication kinetics at the single molecule level. ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us